Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-4-21
pubmed:abstractText
Since cancer cells are characterised by multiple genetic alterations the single inhibition of one tumour- associated gene might not be sufficient as a therapeutic strategy. We examined the effects of a combined inhibition of survivin, human telomerase reverse transcriptase (hTERT) and vascular endothelial growth factor (VEGF) with antisense oligodeoxynucleotides (AS-ODNs) and small interfering RNAs (siRNAs) in EJ28 and 5637 bladder cancer (BCa) cells. Following verification of the uptake of intraperitoneally applied fluorescence-labelled AS-ODNs and siRNAs in subcutaneous BCa xenografts, the target-directed constructs were tested as single agents in SCID mice bearing subcutaneous EJ28. Simultaneous inhibition of two of the selected transcripts significantly enhanced cell viability reduction compared to the controls consisting of a target directed construct and an appropriate control construct without any homology to the human genome. The uptake of both antisense inhibitor types in the subcutaneous BCa was achieved even without a carrier. In vivo studies with 9 consecutive intraperitoneal injections with 20 mg/kg AS-ODNs or 4.6 mg/kg siRNAs revealed the biocompatibility of both antisense inhibitor types and showed anti-tumoural activity of the AS-ODNs used.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/BIRC5 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides, Antisense, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering, http://linkedlifedata.com/resource/pubmed/chemical/TERT protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Telomerase, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1019-6439
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1049-56
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18425331-Animals, pubmed-meshheading:18425331-Cell Line, Tumor, pubmed-meshheading:18425331-Cell Proliferation, pubmed-meshheading:18425331-Cell Survival, pubmed-meshheading:18425331-Down-Regulation, pubmed-meshheading:18425331-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18425331-Humans, pubmed-meshheading:18425331-Inhibitor of Apoptosis Proteins, pubmed-meshheading:18425331-Mice, pubmed-meshheading:18425331-Mice, Nude, pubmed-meshheading:18425331-Mice, SCID, pubmed-meshheading:18425331-Microtubule-Associated Proteins, pubmed-meshheading:18425331-Neoplasm Proteins, pubmed-meshheading:18425331-Oligonucleotides, Antisense, pubmed-meshheading:18425331-RNA, Messenger, pubmed-meshheading:18425331-RNA, Small Interfering, pubmed-meshheading:18425331-RNA Interference, pubmed-meshheading:18425331-Telomerase, pubmed-meshheading:18425331-Time Factors, pubmed-meshheading:18425331-Transfection, pubmed-meshheading:18425331-Transplantation, Heterologous, pubmed-meshheading:18425331-Urinary Bladder Neoplasms, pubmed-meshheading:18425331-Vascular Endothelial Growth Factor A
pubmed:year
2008
pubmed:articleTitle
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
pubmed:affiliation
Department of Urology, Faculty of Medicine, Technical University of Dresden, 01307 Dresden, Germany. doreen.kunze@uniklinikum-dresden.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't